Arthroscopic Superior Capsular Reconstruction With Fascia Lata Autograft - Survivorship of the Autograft Analysis
NCT ID: NCT03663036
Last Updated: 2019-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2018-09-05
2019-09-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to: 1) Evaluate the mid-term outcomes and donor site morbidity impact of FL-ASCR with minimally invasive harvesting; 2) Analyze the mid-term graft integrity to determine its survivorship 3) Establish clinical and imaging graft integrity correlations to guide the future treatment algorithm.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arthroscopic Superior Capsular Reconstruction - Study of Different Types of Grafts
NCT03739749
A Clinical Study Comparing Superior Capsule Reconstruction Using Different Graft for Irreparable Rotator Cuff Tear
NCT04587037
Superior Capsular Reconstruction Versus. Partial Repair for Irreparable Rotator Cuff Tears
NCT04584476
Arthroscopic Rotator Cuff Tear Repair: Single Versus Double Layer Fixation
NCT03362320
The Cross-sectional Area of the Long Head of the Biceps Tendon and the Rotator Cuff Tear Position
NCT05477771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The mid-term shoulder outcomes of ASCR with minimally invasive harvested fascia lata autograft The objective of this task is to establish the 3 years postoperative clinical and radiological shoulder outcomes of FL-ASCR with minimally invasive harvesting. The secondary purpose of this task is to test if the FL-ASCR outcomes remain constant after the 2-year evaluation.
Therefore, the FL-ASCR patients included in this study will have completed the preoperative, 6-month and 2-year postoperative evaluations and will undergo a 3-year postoperative evaluation of:
1. Bilateral shoulder active range of motion (ROM): elevation, abduction and external rotation (with the arm at the side), measured in degrees with the use of an analogic goniometer; and internal rotation, defined as the highest vertebral body that the patient's thumb can reach, converted afterwards to a scale of 1-5 points: lateral thigh=0; buttock=1; sacrum=2; lumbar=3; 12th thoracic vertebra=4; 7th thoracic vertebra=5.);
2. Bilateral shoulder strength (supraspinatus, infraspinatus, subscapularis and teres minor) measured in kilograms with the use of a digital dynamometer;
3. Bilateral functional shoulder scores: the simple shoulder test (SST, 1-12 points), the subjective shoulder value (SSV, 0-100%) and the constant score (CS, 1-100 points).
4. True anteroposterior shoulder view radiograph of the affected shoulder: the acromiohumeral interval (AHI), considering the distance between the top of the humeral head and the undersurface of the acromion, measured using a software measurement tool (PACS, Agfa HealthCare); the RCT arthritis will be graded according to the Hamada revised radiographic classification.
2. The donor site morbidity impact of FL-ASCR with minimally invasive harvesting The objective of this task is to establish the 3-year donor site morbidity subjective impact of FL-ASCR with minimally invasive harvesting. The secondary aim of this task is to test our hypothesis that the subjective impact of the donor site morbidity after FL-ASCR does not change significantly from the 2-year to the 3-year evaluation. Therefore, at the 3-year evaluation, the patients will be required to answer to the same three closed-ended questions that were asked at the 2-year evaluation to assess the donor site morbidity's impact on the patient's overall satisfaction of the surgical procedure: "Does the harvested thigh bother you?", "Does your shoulder surgery's end result compensate for your thigh's changes?", "Would you undergo the same surgery again?". Accordingly, the patients will also be asked asked, in a closed-ended questionnaire, if they noticed any of the following donor site changes: deformity, pain, numbness and specific donor site-related claudication.
Task 2 - Analysis of the mid-term graft integrity on the 3-year postoperative magnetic resonance imaging (MRI) to determine the graft mid-term survivorship
The objective of this task is to determine the 3-year postoperative survivorship of the graft, establishing the fascia lata superior capsular graft tearing rate and the most frequent site of graft failure at 3 years. A 1.5 Tesla MRI scanner (Siemens Magnetom, U.S.A.) will be used to acquire images in the coronal \[proton density fat-saturated (PD FAT-SAT) and T1-weighted\], sagittal (PD FAT-SAT and T2 FAT-SAT) and axial (T2\* and PD) planes. We and, after blinding, two other independent experienced musculoskeletal radiologists will assess the MRI-images from each patient, in order to:
1. Identify any discontinuity of the graft which, if present, will be classified according to its site as a proximal, an intermediate or a distal tear; and as an anterior or a posterior tear.
2. Identify any discontinuity of the onlay repair of the rotator cuff remnants, which, if present, will be classified a tear of the onlay repair.
3. Grade the supraspinatus, infraspinatus, teres minor and subscapularis muscle fatty degeneration according to the Goutallier et al. classification.
4. Grade the RCT tendon remnants retraction in the coronal plane according to the Patte classification.
5. Grade the supraspinatus muscle atrophy according to the Thomazeau et al. classification.
6. Grade the supraspinatus muscle atrophy according to the tangent sign. The graft survivorship according to the three separate evaluations will be compared to establish the inter-observer reliability of the MRI graft survivorship results.
The type of progression of graft integrity will be determined by comparing the 6-month with the 3-year MRI evaluation of the graft survivorship.
Task 3 - Comparative analysis of the clinical, radiological and MRI preoperative and postoperative variables
The objective of this task is to find correlations between the graft survivorship and the results from tasks 1 and 2. The aim is to establish the clinical importance of mid-term graft survivorship.
The investigators will compare the ROM, shoulder strength, SSV, SST, CS and AHI from preoperative to 3 years postoperative; and from 2 years postoperative to 3 years postoperative (paired-samples t-test). The investigators will compare all continuous variables between the group of ASCR patients who underwent an additional onlay partial RCT repair and the group that underwent ASCR without an onlay partial RCT repair, between the anterior acromioplasty-ASCR group and the group that did not undergo an anterior acromioplasty, between the tenotomy-ASCR group and the no-LHBT group, between the preoperative and postoperative AHI\<7mm group and the AHIā„7mm group, and between the intact-graft group and the graft-tear group (Mann-Whitney U test). The investigators will compare all categorical variables, including the donor site morbidity and overall subjective outcome results, between the groups (Fisher's exact test).
To determine the repercussion of FL-ASCR and of the graft integrity on the rotator cuff muscle function the investigators will compare the progression of the Goutallier classification of each rotator cuff muscle from preoperative to 3 years postoperative, as well as the cumulative Goutallier score (the sum of the fatty infiltration stages of the four muscles) and the global fatty muscle degeneration index (the mean value of the grades for the supraspinatus, infraspinatus, and subscapularis), between the intact-graft group and the graft-tear group.
A significant difference will be defined as P\<0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FL-ASCR
Magnetic Resonance Imaging of the shoulder Radiograph of the shoulder
Magnetic Resonance Imaging of the shoulder
Clinical and radiological assessments of the shoulders and the donor sites
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Resonance Imaging of the shoulder
Clinical and radiological assessments of the shoulders and the donor sites
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* completed the preoperative and the 6 months postoperative clinical, radiological and MRI assessments
Exclusion Criteria
* secondary surgery to the harvested thigh
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Hospitalar Lisboa Ocidental
OTHER_GOV
Clara Isabel de Campos Azevedo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clara Isabel de Campos Azevedo
Shoulder Surgery Unit Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clara IC Azevedo, MD
Role: PRINCIPAL_INVESTIGATOR
Centro Hospitalar de Lisboa Ocidental
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Hospitalar de Lisboa Ocidental
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
de Campos Azevedo CI, Angelo ACLPG, Vinga S. Arthroscopic Superior Capsular Reconstruction With a Minimally Invasive Harvested Fascia Lata Autograft Produces Good Clinical Results. Orthop J Sports Med. 2018 Nov 27;6(11):2325967118808242. doi: 10.1177/2325967118808242. eCollection 2018 Nov.
Angelo ACLPG, de Campos Azevedo CI. Minimally invasive fascia lata harvesting in ASCR does not produce significant donor site morbidity. Knee Surg Sports Traumatol Arthrosc. 2019 Jan;27(1):245-250. doi: 10.1007/s00167-018-5085-1. Epub 2018 Aug 1.
Azevedo CIC, Catarina Leiria Pires Gago Angelo A, Campos-Correia D, Delgado L, Ferreira N, Sevivas N. Clinical Importance of Graft Integrity in Arthroscopic Superior Capsular Reconstruction Using a Minimally Invasively Harvested Midthigh Fascia Lata Autograft: 3-Year Clinical and Magnetic Resonance Imaging Outcomes. Am J Sports Med. 2020 Jul;48(9):2115-2128. doi: 10.1177/0363546520928649.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01-2018-07HSFX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.